Hospital Guillermo Grant Benavente

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Crohn's disease1 trial
• High blood pressure1 trial
• Ulcerative colitis1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Hoffmann-La Roche2 trials
• Indiana University1 trial

Running trials

• Recruiting

  A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819878· Phase 3· Hoffmann-La Roche· Source

• Enrolling by invitation

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  NCT06823115· Indiana University· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06589986· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Crohn's disease1 recruiting
• High blood pressure1 recruiting